Postpartum acquired haemophilia: A single centre experience with rituximab

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1166-1168

  Dedeken, L ^a   St Louis, J ^a   Demers, C ^b   Meilleur, C ^a   Rivard, Georges E ^a,c  

^a Quebec Reference Center for Coagulation Inhibitors   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; BLEEDING; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG EFFICACY; ECCHYMOSIS; FEMALE; HEMATOMA; HEMOPHILIA; HUMAN; MATERNAL DISEASE; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM ACQUIRED HEMOPHILIA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; RECURRENT DISEASE; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOSTATICS; HUMANS; IMMUNOLOGIC FACTORS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 69949088264     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02008.x     Document Type: Article

References (5)

1. Collins PW. Treatment of acquired hemophila A. J Thromb Haemost 2007; 5: 893-900.
2. Franchini M. Postpartum acquired factor VIII inhibitors. Am J Hematol 2006; 81: 768-73.
3. Wiestner A, Cho H, Asch A et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426-8.
4. Franchini M, Veneri D, Lippi G, Stenner R. The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders. Thromb Haemost 2006; 96: 119-25.
5. Santoro C, Rago A, De Propis MS et al. Efficacy of rituximab in postpartum acquired haemophilia A. Haemophilia 2008; 14: 147-9.